Portal Veterinary medicinal products

Médicaments vétérinaires

Menu Medicaments Vétérinaires



Stock shortages of veterinary medicinal products

A stock shortage is defined as the impossibility for a person entitled to obtain a veterinary medicinal product on the national market.  

A stock shortage is assessed as critical when it is likely to induce a risk to animal health and welfare or even indirectly to human health.

Good practices for managing stock shortage of a veterinary medicinal product’ were established in 2018 by the various actors in the veterinary medicinal product chain. Updated in 2021, these good practices set out the actions to be taken by each of the players on the veterinary medicinal product market and the arrangements for exchanging information in the event of a stock shortage of a veterinary medicinal product.

Good practices for managing stock shortage in veterinary medicinal supplies (PDF)

Critical stocks shortages should be reported as a matter of priority by the operating laboratories to Anses — ANMV and as early as possible before they occur, in order to study potential alternatives.

To declare a stock shortage

The list of veterinary medicinal products affected by ongoing stock shortage and considered critical can  be found here.

The history of closed critical stocks shortages communicated on the site can be found here (PDF)

If you have any questions about a supply disruption, you can contact the Agency at the following address : DQ_ANMV@anses.fr